The Finance and Accounting Team at 89bio is responsible for managing the company's financial health, overseeing budgeting and forecasting, ensuring regulatory compliance, and providing strategic financial insights to support the development and commercialization of innovative therapies for NASH and severe hypertriglyceridemia.